NOVAST LABS FDA Approval ANDA 206043

ANDA 206043

NOVAST LABS

FDA Drug Application

Application #206043

Application Sponsors

ANDA 206043NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 15MG BASE0PRIMAQUINE PHOSPHATEPRIMAQUINE PHOSPHATE

FDA Submissions

UNKNOWN; ORIG1AP2016-06-23STANDARD

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206043
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PRIMAQUINE PHOSPHATE","activeIngredients":"PRIMAQUINE PHOSPHATE","strength":"EQ 15MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/23\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-06-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.